HFpEF means heart failure with a normal or near-normal ejection fraction. The key issue isn’t the heart’s ability to pump out blood (systolic function) but its ability to fill properly during diastole. The left ventricle is stiff or less compliant, so filling and relaxation are impaired, leading to higher filling pressures and heart‑failure symptoms despite a preserved ejection fraction. That’s why the statement describing decreased filling and relaxation best matches HFpEF in relation to ejection fraction. By contrast, a decreased ejection fraction points to HF with reduced EF, and the other choices describe conditions or contributors that aren’t the defining feature of HFpEF.

After a myocardial infarction, the timing of marker elevation reflects the injury pattern. CK rises about 4–6 hours after onset, peaks around 24 hours, and returns to baseline within roughly 48–72 hours. Troponin I or T rises a bit later, within 3–6 hours, peaks at 12–24 hours, and remains elevated for about 7–10 days (sometimes longer in larger infarcts). This means the statement describing CK elevations lasting 48–72 hours and troponin elevations lasting 7–10 days fits the typical pattern. The other options mix shorter or longer windows than what is usually observed for these markers.

The main idea tested is how thrombosis develops when three interrelated factors come together: a tendency of the blood to clot (hypercoagulability), slow or stagnant blood flow (venous stasis), and injury to the vessel lining (endothelial damage). Hypercoagulability means the blood is more prone to clot due to inherited factors like factor V Leiden or acquired states such as cancer or certain medications. Venous stasis reduces the washout of clotting factors and allows clot formation to proceed, as seen with prolonged immobilization, obesity, or heart failure. Endothelial damage exposes procoagulant surfaces and tissue factor, promoting platelet adhesion and activation of the coagulation cascade. In real life, thrombosis usually results from a combination of these factors rather than a single one. Therefore, the statement that includes all three components is the best description of Virchow's triad.

Ventricular fibrillation is a chaotic, nonpumping rhythm where the heart cannot deliver blood. The immediate management is to deliver a defibrillation shock. This unsynchronized high-energy impulse aims to depolarize the entire myocardium at once, momentarily resetting electrical activity so the heart’s natural pacemaker can regain control and a pulse may return. Time matters—the sooner defibrillation is delivered, the better the chance of return of spontaneous circulation. Other options don’t address the acute electrical chaos: observation won’t restore rhythm, rate control with a beta-blocker is irrelevant during a pulseless arrest, and thrombolysis isn’t an immediate solution for VF and won’t promptly restore circulation in the moment. After the shock, CPR continues and additional ACLS steps are taken as needed.